Tocqueville Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-45,500
| Closed | -$402K | – | 972 |
|
|
2015
Q3 | $402K | Buy |
45,500
+14,400
| +46% | +$127K | 0.01% | 759 |
|
|
2015
Q2 | $366K | Sell |
31,100
-2,900
| -9% | -$34.1K | ﹤0.01% | 792 |
|
|
2015
Q1 | $492K | Buy |
34,000
+15,000
| +79% | +$217K | 0.01% | 720 |
|
|
2014
Q4 | $324K | Sell |
19,000
-3,500
| -16% | -$59.7K | ﹤0.01% | 791 |
|
|
2014
Q3 | $280K | Sell |
22,500
-6,000
| -21% | -$74.7K | ﹤0.01% | 751 |
|
|
2014
Q2 | $418K | Sell |
28,500
-1,000
| -3% | -$14.7K | ﹤0.01% | 767 |
|
|
2014
Q1 | $601K | Buy |
29,500
+11,500
| +64% | +$234K | 0.01% | 539 |
|
|
2013
Q4 | $353K | Buy |
18,000
+6,000
| +50% | +$118K | ﹤0.01% | 667 |
|
|
2013
Q3 | $544K | Sell |
12,000
-6,200
| -34% | -$281K | 0.01% | 622 |
|
|
2013
Q2 | $434K | Buy |
+18,200
| New | +$434K | 0.01% | 668 |
|